价格

NOS-31

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Anti-CD3epsilon antibodies
- US 11440962 B2
  申请人: WUXI BIOLOGICS IRELAND LTD优先权: 2017
  CN
  EP
  US
  WO
  8 件公开
- US 12486325 B2
  申请人: WUXI BIOLOGICS IRELAND LTD优先权: 2022
  US
  2 件公开
WDRPUH EPITOPE PEPTIDES AND VACCINES CONTAINING THE SAME
EP 4047009 A3申请人: ONCOTHERAPY SCIENCE INC优先权: 2008
EP
US
6 件公开
ISOLATED POLYPEPTIDES, POLYNUCLEOTIDES USEFUL FOR MODIFYING WATER USER EFFICIENCY, FERTILIZER USE EFFICIENCY, BIOTIC/ABIOTIC STRESS TOLERANCE, YIELD AND BIOMASS IN PLANTS
US 2011119791 A1申请人: EVOGENE LTD优先权: 2008
US
6 件公开
Anti-CLDN antibody and pharmaceutical composition thereof and detection method therefor
US 12692309 B2申请人: QURE BIOTECHNOLOGY SHANGHAI CO LTD优先权: 2019
CN
EP
US
WO
5 件公开
ANTI-BTLA ANTIBODY
EP 3831851 A4申请人: SHANGHAI JUNSHI BIOSCIENCE CO LTD优先权: 2018
CN
EP
US
4 件公开
Adeno-associated virus variant
US 12480098 B1申请人: AAVATAR THERAPEUTICS CO LTD优先权: 2024
EP
US
WO
4 件公开
ANTI-INTERLEUKIN-17A ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF
EP 3805264 A4申请人: AKESO BIOPHARMA INC优先权: 2018
CN
EP
US
3 件公开
ANTISENSE NUCLEIC ACID CAPABLE OF INHIBITING BIOSYNTHESIS OF CHONDROITIN SULFATE
EP 4495242 A1申请人: AICHI MEDICAL UNIV优先权: 2022
EP
US
WO
3 件公开
Cochlear and/or vestibular cell specific promoter and use thereof
US 20250213728 A1申请人: SHANGHAI EMAYGENE TECH CO LTD优先权: 2022
EP
US
WO
3 件公开
PESTICIDAL ACTX PEPTIDE VARIANTS
EP 4526330 A1申请人: VESTARON CORP优先权: 2022
EP
US
WO
3 件公开

药物

NOS-31

专利

Anti-CD3epsilon antibodies